Shares of health-care companies rose as traders rotated back into high-risk biotech shares, encouraged by a perceived easing of "political risk."
Continue Reading Below
Eli Lilly shares rose after an experimental breast cancer drug showed promise in a clinical trial. Shares of Biogen rose ahead of its earnings report later in the week.
(-By Rob Curran, firstname.lastname@example.org)
(END) Dow Jones Newswires
April 24, 2017 16:21 ET (20:21 GMT)